Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Basil Mohammed Alomair und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, Internal Medicine and Endocrinology, Jouf University, Al-Jouf, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Thrombosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coronavirus disease 2019 (Covid‐19) is caused by a novel severe acute respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global pandemic worldwide. Systemic complications in Covid‐19 are mainly related to the direct SARS‐CoV‐2 cytopathic effects, associated hyperinflammation, hypercytokinemia, and the development of cytokine storm (CS). As well, Covid‐19 complications are developed due to the propagation of oxidative and thrombotic events which may progress to a severe state called oxidative storm and thrombotic storm (TS), respectively. In addition, inflammatory and lipid storms are also developed in Covid‐19 due to the activation of inflammatory cells and the release of bioactive lipids correspondingly. Therefore, the present narrative review aimed to elucidate the interrelated relationship between different storm types in Covid‐19 and the development of the mixed storm (MS). In conclusion, SARS‐CoV‐2 infection induces various storm types including CS, inflammatory storm, lipid storm, TS and oxidative storm. These storms are not developing alone since there is a close relationship between them. Therefore, the MS seems to be more appropriate to be related to severe Covid‐19 than CS, since it develops in Covid‐19 due to the intricate interface between reactive oxygen species, proinflammatory cytokines, complement activation, coagulation disorders, and activated inflammatory signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, Internal Medicine and Endocrinology, Jouf University, Al-Jouf, Saudi Arabia.
- Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.
- Department of Clinical Pharmacology, Medicine, and Therapeutic, Medical Faculty, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq.
- Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
- AFNP Med, Wien, Austria.
- Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, Germany.
ORCID-Profile: Athanasios Alexiou, Majed Ayed Alshammari, Hebatallah M Saad
Zitieren
APA
Alomair, B. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Al-Buhadily, A. K., Alexiou, A., Papadakis, M., Alshammari, M. A., Saad, H. M., & Batiha, G. E. (2023). Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.838
Vancouver
Alomair BM, Al-Kuraishy HM, Al-Gareeb AI, Al-Buhadily AK, Alexiou A, Papadakis M, et al. Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.838
BibTeX
@article{Alomair2023,
author = {Alomair, Basil Mohammed and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Al-Buhadily, Ali K and Alexiou, Athanasios and Papadakis, Marios and Alshammari, Majed Ayed and Saad, Hebatallah M and Batiha, Gaber El-Saber},
title = {Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.838}
}
EUVIMED